Haloperidol

   
Google
 
Web NewDrugInformation.com

Haloperidol


Drug - Haloperidol
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Haloperidol
Multiple ingredients are in alphabetical order.

Strength - 10MG
The potency of the active ingredient(s), Haloperidol. May repeat for multiple part products.

Applicant - SCS
The firm name holding legal responsibility for Haloperidol. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 070724
The FDA assigned number to Haloperidol. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Haloperidol. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 10, 1986
The date Haloperidol was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Haloperidol. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Haloperidol is in. Format is RX, OTC, DISCN.

Applicant Full Name - Scs Pharmaceuticals
The full name of the firm holding legal responsibility for the new application of Haloperidol.

Haloperidol